242 related articles for article (PubMed ID: 27581635)
1. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
3. Natural product-based design, synthesis and biological evaluation of anthra[2,1-d]thiazole-6,11-dione derivatives from rhein as novel antitumour agents.
Liang YK; Yue ZZ; Li JX; Tan C; Miao ZH; Tan WF; Yang CH
Eur J Med Chem; 2014 Sep; 84():505-15. PubMed ID: 25050882
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.
Zhao LM; Ma FY; Jin HS; Zheng S; Zhong Q; Wang G
Eur J Med Chem; 2015 Sep; 102():303-9. PubMed ID: 26291039
[TBL] [Abstract][Full Text] [Related]
5. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
6. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer structure activity relationship investigation of cationic anthraquinone analogs.
Shrestha JP; Fosso MY; Bearss J; Chang CW
Eur J Med Chem; 2014 Apr; 77():96-102. PubMed ID: 24631728
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
9. One Pot and Metal-Free Approach to 3-(2-Hydroxybenzoyl)-1-aza-anthraquinones.
Yuan J; He Q; Song S; Zhang X; Miao Z; Yang C
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434258
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
14. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs.
Draganov AB; Yang X; Anifowose A; De La Cruz LKC; Dai C; Ni N; Chen W; De Los Santos Z; Gu L; Zhou M; Wang B
Bioorg Med Chem; 2019 Sep; 27(17):3860-3865. PubMed ID: 31324563
[TBL] [Abstract][Full Text] [Related]
16. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
17. Novel rhein analogues as potential anticancer agents.
Yang X; Sun G; Yang C; Wang B
ChemMedChem; 2011 Dec; 6(12):2294-301. PubMed ID: 21954017
[TBL] [Abstract][Full Text] [Related]
18. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
Kabir A; Tilekar K; Upadhyay N; Ramaa CS
Anticancer Agents Med Chem; 2018; 18(11):1551-1562. PubMed ID: 29683096
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of natural compound aloe emodin derivatives.
Thimmegowda NR; Park C; Shwetha B; Sakchaisri K; Liu K; Hwang J; Lee S; Jeong SJ; Soung NK; Jang JH; Ryoo IJ; Ahn JS; Erikson RL; Kim BY
Chem Biol Drug Des; 2015 May; 85(5):638-44. PubMed ID: 25323822
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]